ScoreWhy is Elanco Animal Health, Inc. ?
Unrated Stock - No Analysis Available
Real-Time Research ReportHow much should you sell?
- All quantity irrespective of whether you are making profits or losses
(If sector exposure > 30%, please use optimiser tool to see which are the best stocks to hold in Pharmaceuticals & Biotechnology)
When to re-enter? - We will constantly monitor the company and review our call based on new data
Is Elanco Animal Health, Inc. for you?
High Risk, Medium Return
Absolute
Risk Adjusted
Volatility
Elanco Animal Health, Inc.
79.51%
0.41
50.20%
S&P 500
13.22%
0.65
20.20%
Quality
Management Risk
Growth
Capital StructureQuality key factors
Factor
Value
Sales Growth (5y)
9.86%
EBIT Growth (5y)
-0.48%
EBIT to Interest (avg)
0.90
Debt to EBITDA (avg)
5.95
Net Debt to Equity (avg)
0.62
Sales to Capital Employed (avg)
0.38
Tax Ratio
30.41%
Dividend Payout Ratio
0
Pledged Shares
0
Institutional Holding
100.00%
ROCE (avg)
2.12%
ROE (avg)
2.44%
ValuationValuation Key Factors 
Factor
Value
P/E Ratio
14
Industry P/E
Price to Book Value
1.09
EV to EBIT
45.24
EV to EBITDA
12.07
EV to Capital Employed
1.05
EV to Sales
2.44
PEG Ratio
0.03
Dividend Yield
NA
ROCE (Latest)
2.33%
ROE (Latest)
8.05%
TechnicalsTechnical key factors
Indicator
Weekly
Monthly
MACD
Bullish
Bullish
RSI
No Signal
Bearish
Bollinger Bands
Bullish
Bullish
Moving Averages
Bullish (Daily)
KST
Mildly Bearish
Bullish
Dow Theory
Mildly Bullish
Mildly Bullish
OBV
Mildly Bearish
Mildly Bullish
Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish Turned 
Financial Trend13What is working for the Company
NET PROFIT(9M)
At USD 122.48 MM has Grown at 2,962%
OPERATING CASH FLOW(Y)
Highest at USD 572 MM
ROCE(HY)
Highest at 6.83%
RAW MATERIAL COST(Y)
Fallen by 1.39% (YoY
DEBT-EQUITY RATIO
(HY)
Lowest at 54.17 %
DEBTORS TURNOVER RATIO(HY)
Highest at 4.11 times
NET SALES(Q)
Highest at USD 1,241 MM
-9What is not working for the Company
PRE-TAX PROFIT(Q)
At USD 17 MM has Fallen at -89.96%
INTEREST(Q)
At USD 70 MM has Grown at 32.08%
NET PROFIT(Q)
Lowest at USD 7.48 MM
Here's what is working for Elanco Animal Health, Inc.
Operating Cash Flow
Highest at USD 572 MM and Grown
In each year in the last three yearsMOJO Watch
The company has generated higher cash revenues from business operations
Operating Cash Flows (USD MM)
Net Sales
Highest at USD 1,241 MM
in the last five periodsMOJO Watch
Near term sales trend is positive
Net Sales (USD MM)
Debt-Equity Ratio
Lowest at 54.17 %
in the last five Semi-Annual periodsMOJO Watch
The company has been reducing its borrowing as compared to equity capital
Debt-Equity Ratio
Debtors Turnover Ratio
Highest at 4.11 times
in the last five Semi-Annual periodsMOJO Watch
Company has been able to sell its Debtors faster
Debtors Turnover Ratio
Raw Material Cost
Fallen by 1.39% (YoY)
MOJO Watch
The company's ability to pass on the cost of raw materials to customers has improved; this may lead to a rise in profit margin
Raw Material Cost as a percentage of Sales
Here's what is not working for Elanco Animal Health, Inc.
Pre-Tax Profit
At USD 17 MM has Fallen at -89.96%
over average net sales of the previous four periods of USD 169.25 MMMOJO Watch
Near term Pre-Tax Profit trend is very negative
Pre-Tax Profit (USD MM)
Net Profit
At USD 7.48 MM has Fallen at -94.15%
over average net sales of the previous four periods of USD 127.8 MMMOJO Watch
Near term Net Profit trend is very negative
Net Profit (USD MM)
Interest
At USD 70 MM has Grown at 32.08%
period on period (QoQ)MOJO Watch
Rising interest cost signifies increased borrowings
Interest Paid (USD MM)
Net Profit
Lowest at USD 7.48 MM
in the last five periodsMOJO Watch
Near term Net Profit trend is negative
Net Profit (USD MM)
InfinHub Market Technologies FZ-LLC, Building-2, Unit 112, Dubai Internet City, Dubai, United Arab Emirates
GET THE MARKETSMOJO APP
Company
Stocks
Portfolio
"Investment in securities markets are subject to market risk. Read all the related documents carefully before investing."
